Anti-angiogenic cancer vaccinations – a promising future for cancer immunotherapy

In this video, Samuel C. Wagner, President and CEO of Batu Biologics, discusses Facciponte’s study of a TEM-1 DNA vaccination’s efficacy as a cancer therapeutic and the affect of the vaccination on healthy angiogenesis processes in the body.

[iframe url=”” width=”572″ height=”312″]

Watch the video